Srs Capital Advisors, Inc. Vanda Pharmaceuticals Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1,927 shares of VNDA stock, worth $8,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,927Holding current value
$8,748% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
45.1MCall Options Held
136KPut Options Held
220K-
Black Rock Inc. New York, NY8.14MShares$36.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.11MShares$18.7 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$15.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$9.78 Million1.49% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.01MShares$9.14 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $257M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...